pharmaphorum
DECEMBER 23, 2022
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Seamless data sharing between clinical teams and medical science liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement.
Impetus Digital
APRIL 24, 2023
Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. MA and the healthcare community are increasingly embracing new ways of thinking about scientific data, tailoring this to different channels.
Pharmaceutical Technology
JULY 10, 2008
.” Unlike the US where the Food and Drug Administration has been slated for delaying the approval of new medicines, Ley says the British industry has no quarrel with the Medicines and Healthcare products Regulatory Agency. “It’s very disappointing.
Expert insights. Personalized for you.
94 
Let's personalize your content